{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:54:14Z","timestamp":1790823254859,"version":"4.1.0"},"reference-count":47,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>\n                    Historically, because of the difficulty of using warfarin safely and effectively, many patients with cardioembolic stroke who should have been anticoagulated were instead given ineffective antiplatelet therapy (or no antithrombotic therapy). With the arrival of new oral anticoagulants that are not significantly more likely than aspirin to cause severe haemorrhage, everything has changed. Because antiplatelet agents are much less effective in preventing cardioembolic stroke, it is now more prudent to anticoagulate patients in whom cardioembolic stroke is strongly suspected. Recent advances include the recognition that intermittent atrial fibrillation is better detected with more prolonged monitoring of the cardiac rhythm, and that percutaneous closure of patent foramen ovale (PFO) may reduce the risk of stroke. However, because in most patients with stroke and PFO the PFO is incidental, this should be reserved for patients in whom paradoxical embolism is likely. A high shunt grade on transcranial Doppler saline studies, and clinical clues to paradoxical embolism, can help in appropriate selection of patients for percutaneous closure. For patients with atrial fibrillation who cannot be anticoagulated, ablation of the left atrial appendage is an emerging option. It is also increasingly recognised that high levels of homocysteine, often due to undiagnosed metabolic deficiency of vitamin B\n                    <jats:sub>12<\/jats:sub>\n                    , markedly increase the risk of stroke in atrial fibrillation, and that B vitamins (folic acid and B\n                    <jats:sub>12<\/jats:sub>\n                    ) do prevent stroke by lowering homocysteine. However, with regard to B\n                    <jats:sub>12<\/jats:sub>\n                    , methylcobalamin should probably be used instead of cyanocobalamin. Many important considerations for judicious application of therapies to prevent cardioembolic stroke are discussed.\n                  <\/jats:p>","DOI":"10.1136\/svn-2018-000143","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T20:10:10Z","timestamp":1520712610000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":45,"title":["Cardioembolic stroke: everything has changed"],"prefix":"10.1136","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7478-1098","authenticated-orcid":false,"given":"J David","family":"Spence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"2020050723410029000_3.2.76.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05388-X"},{"key":"2020050723410029000_3.2.76.2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"2020050723410029000_3.2.76.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0906549"},{"key":"2020050723410029000_3.2.76.4","unstructured":"Spence JD , Barnett HJM , Prevention S . Treatment and rehabilitation. New York: McGraw-Hill Medical Publishers, 2012."},{"key":"2020050723410029000_3.2.76.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70310-7"},{"key":"2020050723410029000_3.2.76.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311376"},{"key":"2020050723410029000_3.2.76.7","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.cjca.2015.12.009","article-title":"Transcranial doppler is complementary to echocardiography for detection and risk stratification of patent foramen ovale","volume":"32","author":"Tobe","year":"2016","journal-title":"Can J Cardiol"},{"key":"2020050723410029000_3.2.76.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2015.10.003"},{"key":"2020050723410029000_3.2.76.9","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1474-4422(17)30180-1","article-title":"B vitamins in stroke prevention: time to reconsider","volume":"16","author":"Spence","year":"2017","journal-title":"Lancet Neurol"},{"key":"2020050723410029000_3.2.76.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198705283162204"},{"key":"2020050723410029000_3.2.76.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000042207.16156.B9"},{"key":"2020050723410029000_3.2.76.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000110981.96204.64"},{"key":"2020050723410029000_3.2.76.13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaneurol.2015.1843","article-title":"Risk of Stroke at the Time of Carotid Occlusion","volume":"72","author":"Yang","year":"2015","journal-title":"JAMA Neurol"},{"key":"2020050723410029000_3.2.76.14","doi-asserted-by":"publisher","DOI":"10.1159\/000362417"},{"key":"2020050723410029000_3.2.76.15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006536"},{"key":"2020050723410029000_3.2.76.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412981"},{"key":"2020050723410029000_3.2.76.17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121218"},{"key":"2020050723410029000_3.2.76.18","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.516344"},{"key":"2020050723410029000_3.2.76.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-9-201111010-00004"},{"key":"2020050723410029000_3.2.76.20","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afv156"},{"key":"2020050723410029000_3.2.76.21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.7.677"},{"key":"2020050723410029000_3.2.76.22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv730"},{"key":"2020050723410029000_3.2.76.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008714"},{"key":"2020050723410029000_3.2.76.24","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.595140"},{"key":"2020050723410029000_3.2.76.25","unstructured":"Hutchinson EC , Acheson EJ . Strokes: natural history`, pathology and surgical treatment. Philadelphia: W.B. Saunders, 1975."},{"key":"2020050723410029000_3.2.76.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.08.018"},{"key":"2020050723410029000_3.2.76.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.023"},{"key":"2020050723410029000_3.2.76.28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"2020050723410029000_3.2.76.29","unstructured":"S\u00f8ndergaard L , Kasner SE , Rhodes JF , et al . Stroke Prevention with Closure of Patent Foramen Ovale after Cryptogenic Stroke. N Engl J Med. 2017. In\u00a0Press."},{"key":"2020050723410029000_3.2.76.30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"2020050723410029000_3.2.76.31","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000127986.51105.57"},{"key":"2020050723410029000_3.2.76.32","doi-asserted-by":"publisher","DOI":"10.1159\/000096149"},{"key":"2020050723410029000_3.2.76.33","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.128678"},{"key":"2020050723410029000_3.2.76.34","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000236633.40160.ee"},{"key":"2020050723410029000_3.2.76.35","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000183620.06179.7b"},{"key":"2020050723410029000_3.2.76.36","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.22.8.983"},{"key":"2020050723410029000_3.2.76.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(99)90048-6"},{"key":"2020050723410029000_3.2.76.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(98)90130-8"},{"key":"2020050723410029000_3.2.76.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.104"},{"key":"2020050723410029000_3.2.76.40"},{"key":"2020050723410029000_3.2.76.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432"},{"key":"2020050723410029000_3.2.76.42","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"2020050723410029000_3.2.76.43","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1253\/circj.CJ-11-0564","article-title":"Thrombin inhibitor or factor xa inhibitor? -Opening of a New Era of antithrombotic management-","volume":"75","author":"Atarashi","year":"2011","journal-title":"Circ J"},{"key":"2020050723410029000_3.2.76.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708078"},{"key":"2020050723410029000_3.2.76.45","doi-asserted-by":"crossref","unstructured":"Spence JD . Atrial fibrillation and stroke prevention: is warfarin still an option? Yes: Debate at the Controversies in Neurology congress, Beijing October 2011. J. Neural Transm;2012.","DOI":"10.1007\/s00702-012-0941-5"},{"key":"2020050723410029000_3.2.76.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02715.x"},{"key":"2020050723410029000_3.2.76.47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJM199811123392002","article-title":"Benefit of carotid endarterectomy in patients with symptomatic moderate or severe carotid stenosis","volume":"339","author":"Barnett","year":"1998","journal-title":"N Engl J Med Overseas Ed"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2018-000143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:54:42Z","timestamp":1601056482000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2018-000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6,26]]},"published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1136\/svn-2018-000143"],"URL":"https:\/\/doi.org\/10.1136\/svn-2018-000143","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}